Key facts
| Price (PPV) | 1,707 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ganirelix |
| Class | Pituitary and hypothalamic hormones |
| ATC code | H01CC01 |
| Manufacturer | COOPER PHARMA |
| Presentation | Boîte de 5 |
| Nature | Médicament |
| Hospital price | 1,448 MAD |
| Data collected on | 9/8/2026 |
Indications
ORGALUTRAN est indiqué dans la prévention des pics prématurés d'hormone lutéinisante (LH) chez les femmes en cours d'hyperstimulation ovarienne contrôlée (HOC) dans le cadre des techniques d'assistance médicale à la procréation (AMP). Dans les études cliniques, ORGALUTRAN a été utilisé en association avec une hormone folliculo-stimulante humaine recombinante (FSH) ou la corifollitropine alfa, stimulant folliculaire à action prolongée.
Find an open pharmacy
On-call pharmacies near you
About Orgalutran 0.25 mg / 0.5 ml
Orgalutran 0.25 mg / 0.5 ml belongs to the pituitary and hypothalamic hormones therapeutic class. In Morocco, this drug is marketed by COOPER PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Orgalutran 0.25 mg / 0.5 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Orgalutran 0.25 mg / 0.5 ml
Answers to common questions from Moroccan patients about this drug.